Author
Listed:
- Haonan Zhang
(CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences
State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences
University of Chinese Academy of Sciences)
- Anna Qiao
(CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences
State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences
University of Chinese Academy of Sciences)
- Linlin Yang
(School of Basic Medical Sciences, Zhengzhou University)
- Ned Van Eps
(University of Toronto)
- Klaus S. Frederiksen
(Novo Nordisk A/S, Novo Nordisk Park)
- Dehua Yang
(CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences
The National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 189 Guo Shou Jing Road, Pudong)
- Antao Dai
(CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences
The National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 189 Guo Shou Jing Road, Pudong)
- Xiaoqing Cai
(CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences
The National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 189 Guo Shou Jing Road, Pudong)
- Hui Zhang
(CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences
University of Chinese Academy of Sciences)
- Cuiying Yi
(CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences)
- Can Cao
(University of Chinese Academy of Sciences
National Laboratory of Biomacromolecules, National Center of Protein Science - Beijing, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences)
- Lingli He
(National Laboratory of Biomacromolecules, National Center of Protein Science - Beijing, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences)
- Huaiyu Yang
(Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University)
- Jesper Lau
(Novo Nordisk A/S, Novo Nordisk Park)
- Oliver P. Ernst
(University of Toronto
University of Toronto, Toronto)
- Michael A. Hanson
(GPCR Consortium, San Marcos)
- Raymond C. Stevens
(iHuman Institute, ShanghaiTech University
School of Life Science and Technology, ShanghaiTech University)
- Ming-Wei Wang
(CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences
University of Chinese Academy of Sciences
The National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 189 Guo Shou Jing Road, Pudong
School of Life Science and Technology, ShanghaiTech University)
- Steffen Reedtz-Runge
(Novo Nordisk A/S, Novo Nordisk Park)
- Hualiang Jiang
(CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences
State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences
Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences)
- Qiang Zhao
(CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences
State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences
University of Chinese Academy of Sciences
CAS Center for Excellence in Biomacromolecules, Chinese Academy of Sciences)
- Beili Wu
(CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences
University of Chinese Academy of Sciences
School of Life Science and Technology, ShanghaiTech University
CAS Center for Excellence in Biomacromolecules, Chinese Academy of Sciences)
Abstract
The crystal structure of the full-length glucagon receptor in complex with a glucagon analogue NNC1702 reveals how the peptide ligand interacts with its target and shows the conformational changes required for receptor activation.
Suggested Citation
Haonan Zhang & Anna Qiao & Linlin Yang & Ned Van Eps & Klaus S. Frederiksen & Dehua Yang & Antao Dai & Xiaoqing Cai & Hui Zhang & Cuiying Yi & Can Cao & Lingli He & Huaiyu Yang & Jesper Lau & Oliver P, 2018.
"Structure of the glucagon receptor in complex with a glucagon analogue,"
Nature, Nature, vol. 553(7686), pages 106-110, January.
Handle:
RePEc:nat:nature:v:553:y:2018:i:7686:d:10.1038_nature25153
DOI: 10.1038/nature25153
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:553:y:2018:i:7686:d:10.1038_nature25153. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.